(From the application): The goals of the Transgenic, Tissue, and Protein Analysis Core Laboratory are: 1) to provide data management services, including responsibility for collection, archiving and cataloging of incoming data; generation of data correction requests for missing, inconsistent or out-of- range data items; and, for production of SAS-readable data sets for analysis by the biostatistician, who will also provide assistance in study design and data analysis; 2) to facilitate the use of transgenic animals (especially for maintaining transgenic lines, backcrossing and crossbreeding); 3) to analyze amyloid beta-peptide (A-beta) brains of transgenic animals and to assist in the characterization of mutant recombinant proteins (variant forms of ABAD); and 4) to assist in neuropathologic analysis of transgenic mouse brain tissue. The Core Laboratory uses the 17th flood of the P&S Building as a home base, in order to be in close proximity to the laboratories of the investigators involved in the PPG, since the Core Lab will be used by all projects. Animals are housed in the Institute of Comparative Medicine on the 18th floor of the same building. Certain specialized functions of the Core will be performed at the Sun Health Research Institute (determination of A- beta[1-40] and A-beta[1-42] levels and protein analysis) and at the Massachusetts General Hospital (neuropathologic analysis, which will be coordinated between a unit of the Core Lab at MGH). The Core will coordinate interactions among investigators working on the projects at Columbia and investigators participating in Core B based at other institutions. In addition, the Core Laboratory maintains microtomes for making routine frozen and EM sections, and a microscopy core for histologic/immunohistologic analyses.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
1P01AG017490-01A1
Application #
6310399
Study Section
Special Emphasis Panel (ZAG1)
Project Start
2000-09-01
Project End
2005-06-30
Budget Start
Budget End
Support Year
1
Fiscal Year
2000
Total Cost
Indirect Cost
Name
Columbia University (N.Y.)
Department
Type
DUNS #
167204994
City
New York
State
NY
Country
United States
Zip Code
10032
Juranek, Judyta K; Daffu, Gurdip K; Geddis, Matthew S et al. (2016) Soluble RAGE Treatment Delays Progression of Amyotrophic Lateral Sclerosis in SOD1 Mice. Front Cell Neurosci 10:117
Carlson, Emily A; Marquez, Rebecca T; Du, Fang et al. (2015) Overexpression of 17?-hydroxysteroid dehydrogenase type 10 increases pheochromocytoma cell growth and resistance to cell death. BMC Cancer 15:166
Du, Heng; Guo, Lan; Wu, Xiaoping et al. (2014) Cyclophilin D deficiency rescues A?-impaired PKA/CREB signaling and alleviates synaptic degeneration. Biochim Biophys Acta 1842:2517-27
Juranek, Judyta K; Geddis, Matthew S; Rosario, Rosa et al. (2013) Impaired slow axonal transport in diabetic peripheral nerve is independent of RAGE. Eur J Neurosci 38:3159-68
Borger, Eva; Aitken, Laura; Du, Heng et al. (2013) Is amyloid binding alcohol dehydrogenase a drug target for treating Alzheimer's disease? Curr Alzheimer Res 10:21-9
Juranek, Judyta K; Geddis, Matthew S; Song, Fei et al. (2013) RAGE deficiency improves postinjury sciatic nerve regeneration in type 1 diabetic mice. Diabetes 62:931-43
Du, Heng; Guo, Lan; Yan, Shirley ShiDu (2012) Synaptic mitochondrial pathology in Alzheimer's disease. Antioxid Redox Signal 16:1467-75
Huang, Tianwen; Fang, Fang; Chen, Limin et al. (2012) Ginsenoside Rg1 attenuates oligomeric A?(1-42)-induced mitochondrial dysfunction. Curr Alzheimer Res 9:388-95
Carnevale, Daniela; Mascio, Giada; D'Andrea, Ivana et al. (2012) Hypertension induces brain ?-amyloid accumulation, cognitive impairment, and memory deterioration through activation of receptor for advanced glycation end products in brain vasculature. Hypertension 60:188-97
Yan, Shirley ShiDu; Chen, Doris; Yan, Shiqian et al. (2012) RAGE is a key cellular target for Abeta-induced perturbation in Alzheimer's disease. Front Biosci (Schol Ed) 4:240-50

Showing the most recent 10 out of 68 publications